Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 289

1.

Spontaneous coronary artery dissection in cardiac sarcoidosis.

Kandolin R, Ekström K, Simard T, Hibbert B, Nery P, Lehtonen J, Kupari M, Birnie D.

Oxf Med Case Reports. 2019 May 31;2019(5):omz033. doi: 10.1093/omcr/omz033. eCollection 2019 May.

2.

Adaptive cardiac resynchronization therapy is associated with decreased risk of incident atrial fibrillation compared to standard biventricular pacing: A real-world analysis of 37,450 patients followed by remote monitoring.

Hsu JC, Birnie D, Stadler RW, Cerkvenik J, Feld GK, Birgersdotter-Green U.

Heart Rhythm. 2019 May 16. pii: S1547-5271(19)30452-7. doi: 10.1016/j.hrthm.2019.05.012. [Epub ahead of print]

3.

Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial.

Essebag V, AlTurki A, Proietti R, Healey JS, Wells GA, Verma A, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leather R, Ahmad K, Toal S, Sapp J, Sturmer M, Kavanagh K, Crystal E, Leiria TLL, Seifer C, Rinne C, Birnie D; BRUISE CONTROL Investigators.

Int J Cardiol. 2019 Aug 1;288:87-93. doi: 10.1016/j.ijcard.2019.04.066. Epub 2019 Apr 26.

PMID:
31056413
4.

Patient-specific labial fixed appliances: a step towards personalised orthodontic care?

Birnie D.

J Orthod. 2019 Jun;46(1_suppl):65-70. doi: 10.1177/1465312519840034. Epub 2019 Mar 27.

PMID:
31056023
5.

Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome.

Cheung CC, Mellor G, Deyell MW, Ensam B, Batchvarov V, Papadakis M, Roberts JD, Leather R, Sanatani S, Healey JS, Chauhan VS, Birnie DH, Champagne J, Angaran P, Klein GJ, Yee R, Simpson CS, Talajic M, Gardner M, Yeung-Lai-Wah JA, Chakrabarti S, Laksman ZW, Sharma S, Behr ER, Krahn AD.

JACC Clin Electrophysiol. 2019 Apr;5(4):504-512. doi: 10.1016/j.jacep.2019.01.026. Epub 2019 Mar 27.

PMID:
31000106
6.

Adaptive Cardiac Resynchronization Therapy Reduces Atrial Fibrillation Incidence in Heart Failure Patients With Prolonged AV Conduction.

Gasparini M, Birnie D, Lemke B, Aonuma K, Lee KL, Gorcsan J 3rd, Landolina M, Klepfer R, Meloni S, Cicconelli M, Grammatico A, Martin DO.

Circ Arrhythm Electrophysiol. 2019 May;12(5):e007260. doi: 10.1161/CIRCEP.119.007260. No abstract available.

PMID:
30991823
7.

Improving first shock success in patients with atrial fibrillation undergoing electrical cardioversion: Authors' reply.

Ramirez FD, Sadek MM, Birnie DH.

Europace. 2019 Mar 20. pii: euz048. doi: 10.1093/europace/euz048. [Epub ahead of print] No abstract available.

PMID:
30897610
8.

Letter to the Editor regarding the paper "Cardioversion of atrial fibrillation in obese patients: Results from the Cardioversion-BMI randomized controlled trial".

Ramirez FD, Sadek MM, Birnie DH.

J Cardiovasc Electrophysiol. 2019 Mar 18. doi: 10.1111/jce.13910. [Epub ahead of print] No abstract available.

PMID:
30887611
9.

Prevention of Arrhythmia Device Infection Trial: The PADIT Trial.

Krahn AD, Longtin Y, Philippon F, Birnie DH, Manlucu J, Angaran P, Rinne C, Coutu B, Low RA, Essebag V, Morillo C, Redfearn D, Toal S, Becker G, Degrâce M, Thibault B, Crystal E, Tung S, LeMaitre J, Sultan O, Bennett M, Bashir J, Ayala-Paredes F, Gervais P, Rioux L, Hemels MEW, Bouwels LHR, van Vlies B, Wang J, Exner DV, Dorian P, Parkash R, Alings M, Connolly SJ.

J Am Coll Cardiol. 2018 Dec 18;72(24):3098-3109. doi: 10.1016/j.jacc.2018.09.068.

PMID:
30545448
10.

Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol.

Ramirez FD, Sadek MM, Boileau I, Cleland M, Nery PB, Nair GM, Redpath CJ, Green MS, Davis DR, Charron K, Henne J, Zakutney T, Beanlands RSB, Hibbert B, Wells GA, Birnie DH.

Europace. 2018 Dec 7. doi: 10.1093/europace/euy285. [Epub ahead of print]

PMID:
30535367
11.

To continue or minimally interrupt direct oral anticoagulants around ablation for atrial fibrillation: that is the question.

Birnie DH.

Europace. 2019 Apr 1;21(4):531-532. doi: 10.1093/europace/euy278. No abstract available.

PMID:
30496402
12.

Postablation Atrial Fibrillation Burden and Patient Activity Level: Insights From the DISCERN AF Study.

Proietti R, Birnie D, Ziegler PD, Wells GA, Verma A.

J Am Heart Assoc. 2018 Dec 4;7(23):e010256. doi: 10.1161/JAHA.118.010256.

13.

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).

Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, Essebag V.

Eur Heart J. 2018 Nov 21;39(44):3973-3979. doi: 10.1093/eurheartj/ehy413.

PMID:
30462279
14.

The Impact of Cardiac Rehabilitation on Mental and Physical Health in Patients With Atrial Fibrillation: A Matched Case-Control Study.

Reed JL, Clarke AE, Faraz AM, Birnie DH, Tulloch HE, Reid RD, Pipe AL.

Can J Cardiol. 2018 Nov;34(11):1512-1521. doi: 10.1016/j.cjca.2018.08.035. Epub 2018 Aug 30.

PMID:
30404754
15.

Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate Subjects.

Mondésert B, Bashir J, Philippon F, Dubuc M, Amit G, Exner D, Joza J, Birnie DH, Lane C, Tsang B, Korley V, Spears D, Ling A, Djuric A, Crystal E, Hruczkowski T, Roux JF, Carroll S, Essebag V, Krahn AD, Healey JS.

Am Heart J. 2019 Jan;207:1-9. doi: 10.1016/j.ahj.2018.09.008. Epub 2018 Oct 9.

PMID:
30399474
16.

Which Patients With Cardiac Sarcoidosis Should Receive Implantable Cardioverter-Defibrillators.

Birnie D, Ha A, Kron J.

Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006685. doi: 10.1161/CIRCEP.118.006685. No abstract available.

PMID:
30354325
17.

Prevention of venous thrombosis after electrophysiology procedures: a survey of national practice.

Burstein B, Barbosa RS, Samuel M, Kalfon E, Philippon F, Birnie D, Mangat I, Redfearn D, Sandhu R, Macle L, Sapp J, Verma A, Healey JS, Becker G, Chauhan V, Coutu B, Roux JF, Leong-Sit P, Andrade JG, Veenhuyzen GD, Joza J, Bernier M, Essebag V.

J Interv Card Electrophysiol. 2018 Dec;53(3):357-363. doi: 10.1007/s10840-018-0461-9. Epub 2018 Oct 8.

PMID:
30298364
18.

Prevalence and Significance of Tricuspid Regurgitation Post-Endocardial Lead Placement.

Anvardeen K, Rao R, Hazra S, Hay K, Dai H, Stoyanov N, Birnie D, Dwivedi G, Chan KL.

JACC Cardiovasc Imaging. 2019 Mar;12(3):562-564. doi: 10.1016/j.jcmg.2018.07.009. Epub 2018 Sep 12. No abstract available.

PMID:
30219404
19.

Completely nonfluoroscopic catheter ablation of left atrial arrhythmias and ventricular tachycardia.

Sadek MM, Ramirez FD, Nery PB, Golian M, Redpath CJ, Nair GM, Birnie DH.

J Cardiovasc Electrophysiol. 2019 Jan;30(1):78-88. doi: 10.1111/jce.13735. Epub 2018 Oct 22.

PMID:
30203499
20.

Characterization of Low-Voltage Areas in Patients With Atrial Fibrillation: Insights From High-Density Intracardiac Mapping.

Nery PB, Al Dawood W, Nair GM, Redpath CJ, Sadek MM, Chen L, Green MS, Wells G, Birnie DH.

Can J Cardiol. 2018 Aug;34(8):1033-1040. doi: 10.1016/j.cjca.2018.04.008. Epub 2018 Apr 12.

PMID:
30056843
21.

Heart Transplantation for End-Stage Cardiac Sarcoidosis: Increasingly Used With Excellent Results.

Toma M, Birnie D.

Can J Cardiol. 2018 Aug;34(8):956-958. doi: 10.1016/j.cjca.2018.04.018. Epub 2018 Apr 25. No abstract available.

PMID:
30049363
22.

Mitral valve repair results in suppression of ventricular arrhythmias and normalization of repolarization abnormalities in mitral valve prolapse.

Alqarawi W, Birnie DH, Burwash IG.

HeartRhythm Case Rep. 2018 Mar 2;4(5):191-194. doi: 10.1016/j.hrcr.2018.02.012. eCollection 2018 May. No abstract available.

23.

Prevalence of left atrial appendage thrombus detected by transoesophageal echocardiography before catheter ablation of atrial fibrillation in patients anticoagulated with non-vitamin K antagonist oral anticoagulants.

Alqarawi W, Birnie DH, Spence S, Ramirez FD, Redpath CJ, Lemery R, Nair GM, Nery PB, Davis DR, Green MS, Beauchesne L, Chan K, Ascah K, Burwash I, Sadek MM.

Europace. 2019 Jan 1;21(1):48-53. doi: 10.1093/europace/euy129.

PMID:
29897439
24.

Bi-atrial fibrosis detected using three-dimensional late gadolinium enhancement magnetic resonance imaging in a patient with cardiac sarcoidosis.

Spence S, Pena E, Thornhill RE, Nery PB, Birnie DH.

Oxf Med Case Reports. 2018 May 16;2018(5):omy016. doi: 10.1093/omcr/omy016. eCollection 2018 May.

25.

Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing.

Bennett MT, Leader N, Sapp J, Parkash R, Gardner M, Healey JS, Thibault B, Sterns L, Essebag V, Birnie D, Sivakumaran S, Nery P, Andrade JG, Krahn AD, Tang A.

Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005921. doi: 10.1161/CIRCEP.117.005921.

PMID:
29618476
26.

User-centered Development of a Decision Aid for Patients Facing Implantable Cardioverter-Defibrillator Replacement: A Mixed-Methods Study.

Lewis KB, Birnie D, Carroll SL, Clark L, Kelly F, Gibson P, Rockburn L, Rockburn L, Stacey D.

J Cardiovasc Nurs. 2018 Sep/Oct;33(5):481-491. doi: 10.1097/JCN.0000000000000477.

PMID:
29601374
27.

Association between transthoracic impedance and electrical cardioversion success with biphasic defibrillators: An analysis of 1055 shocks for atrial fibrillation and flutter.

Sadek MM, Chaugai V, Cleland MJ, Zakutney TJ, Birnie DH, Ramirez FD.

Clin Cardiol. 2018 May;41(5):666-670. doi: 10.1002/clc.22947. Epub 2018 May 11.

28.

The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial.

Verma A, Ha ACT, Kirchhof P, Hindricks G, Healey JS, Hill MD, Sharma M, Wyse DG, Champagne J, Essebag V, Wells G, Gupta D, Heidbuchel H, Sanders P, Birnie DH.

Am Heart J. 2018 Mar;197:124-132. doi: 10.1016/j.ahj.2017.12.007. Epub 2017 Dec 8.

PMID:
29447772
29.

Bidirectional ventricular tachycardia in ischemic cardiomyopathy during ablation.

Yeo C, Green MS, Nair GM, Birnie DH, Nery PB, Sadek MM.

HeartRhythm Case Rep. 2017 Sep 5;3(11):527-530. doi: 10.1016/j.hrcr.2017.08.005. eCollection 2017 Nov. No abstract available.

30.

How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body 18F-fluorodeoxyglucose positron emission tomography.

Juneau D, Nery P, Russo J, de Kemp RA, Leung E, Beanlands RSB, Birnie DH.

Int J Cardiol. 2018 Feb 15;253:189-193. doi: 10.1016/j.ijcard.2017.09.204.

PMID:
29306462
31.

Incorporating patients' preference diagnosis in implantable cardioverter defibrillator decision-making: a review of recent literature.

Lewis KB, Carroll SL, Birnie D, Stacey D, Matlock DD.

Curr Opin Cardiol. 2018 Jan;33(1):42-49. doi: 10.1097/HCO.0000000000000464. Review.

PMID:
29216014
32.

Reply: Using and Interpreting 18F-FDG PET/CT Images in Patients Referred for Assessment of Cardiac Sarcoidosis: The Devil Is in the Details.

Birnie D, Ohira H, Beanlands R.

J Nucl Med. 2017 Dec;58(12):2040. doi: 10.2967/jnumed.117.198226. Epub 2017 Oct 19. No abstract available.

33.

Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial.

Birnie D, Hudnall H, Lemke B, Aonuma K, Lee KL, Gasparini M, Gorcsan J 3rd, Cerkvenik J, Martin DO.

Heart Rhythm. 2017 Dec;14(12):1820-1825. doi: 10.1016/j.hrthm.2017.08.017. Epub 2017 Sep 9.

34.

Efficacy and safety of driver-guided catheter ablation for atrial fibrillation: A systematic review and meta-analysis.

Ramirez FD, Birnie DH, Nair GM, Szczotka A, Redpath CJ, Sadek MM, Nery PB.

J Cardiovasc Electrophysiol. 2017 Dec;28(12):1371-1378. doi: 10.1111/jce.13313. Epub 2017 Sep 5. Review.

PMID:
28800192
35.

Subclinical Atrial Fibrillation in Older Patients.

Healey JS, Alings M, Ha A, Leong-Sit P, Birnie DH, de Graaf JJ, Freericks M, Verma A, Wang J, Leong D, Dokainish H, Philippon F, Barake W, McIntyre WF, Simek K, Hill MD, Mehta SR, Carlson M, Smeele F, Pandey AS, Connolly SJ; ASSERT-II Investigators.

Circulation. 2017 Oct 3;136(14):1276-1283. doi: 10.1161/CIRCULATIONAHA.117.028845. Epub 2017 Aug 4.

PMID:
28778946
36.

Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, Birnie DH, Chen ES, Cooper LT, Tung RH, White ES, Borges-Neto S, Di Carli MF, Gropler RJ, Ruddy TD, Schindler TH, Blankstein R.

J Nucl Cardiol. 2017 Oct;24(5):1741-1758. doi: 10.1007/s12350-017-0978-9. No abstract available.

PMID:
28770463
37.

Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.

Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, Birnie DH, Chen ES, Cooper LT, Tung RH, White ES, Borges-Neto S, Di Carli MF, Gropler RJ, Ruddy TD, Schindler TH, Blankstein R; NAME OF COLLAB GROUP.

J Nucl Med. 2017 Aug;58(8):1341-1353. doi: 10.2967/jnumed.117.196287. No abstract available.

38.

Management of Implantable Cardioverter Defibrillator Recipients: Care Beyond Guidelines.

Philippon F, Sterns LD, Nery PB, Parkash R, Birnie D, Rinne C, Mondesert B, Exner D, Bennett M.

Can J Cardiol. 2017 Aug;33(8):977-990. doi: 10.1016/j.cjca.2017.05.012. Epub 2017 May 26. Review.

PMID:
28754398
39.

Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing.

Filippatos G, Birnie D, Gold MR, Gerritse B, Hersi A, Jacobs S, Kusano K, Leclercq C, Mullens W, Wilkoff BL; AdaptResponse Investigators.

Eur J Heart Fail. 2017 Jul;19(7):950-957. doi: 10.1002/ejhf.895. Review.

40.

Three-year outcomes and reconnection patterns after initial contact force guided pulmonary vein isolation for paroxysmal atrial fibrillation.

Nair GM, Yeo C, MacDonald Z, Ainslie MP, Alqarawi WA, Nery PB, Redpath CJ, Sadek M, Spence S, Green MS, Birnie DH.

J Cardiovasc Electrophysiol. 2017 Sep;28(9):984-993. doi: 10.1111/jce.13280. Epub 2017 Sep 1.

PMID:
28635046
41.

Letter by Nery et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".

Nery PB, Lewis KB, Birnie DH.

Circulation. 2017 Jun 20;135(25):e1198-e1199. doi: 10.1161/CIRCULATIONAHA.117.027389. No abstract available.

PMID:
28630274
42.

A case of pacemaker "malfunction". Should I intervene?

Yeo C, Birnie DH, Nair GM.

J Electrocardiol. 2017 Nov - Dec;50(6):939-940. doi: 10.1016/j.jelectrocard.2017.06.017. Epub 2017 Jun 8.

PMID:
28624117
43.

Genetic Testing in the Evaluation of Unexplained Cardiac Arrest: From the CASPER (Cardiac Arrest Survivors With Preserved Ejection Fraction Registry).

Mellor G, Laksman ZWM, Tadros R, Roberts JD, Gerull B, Simpson CS, Klein GJ, Champagne J, Talajic M, Gardner M, Steinberg C, Arbour L, Birnie DH, Angaran P, Leather R, Sanatani S, Chauhan VS, Seifer C, Healey JS, Krahn AD.

Circ Cardiovasc Genet. 2017 Jun;10(3). pii: e001686. doi: 10.1161/CIRCGENETICS.116.001686.

PMID:
28600387
44.

Between- and within-site variation in medication choices and adverse events during procedural sedation for electrical cardioversion of atrial fibrillation and flutter.

Clinkard D, Stiell I, Lang E, Rose S, Clement C, Brison R, Rowe BH, Borgundvaag B, Langhan T, Magee K, Stenstrom R, Perry JJ, Birnie D, Wells G, McRae A.

CJEM. 2018 May;20(3):370-376. doi: 10.1017/cem.2017.20. Epub 2017 Jun 7.

PMID:
28587704
45.

Late resolution of pacemaker lead-related severe tricuspid regurgitation and right ventricular dysfunction after percutaneous lead extraction: A case report and review of the literature.

Ramirez FD, Almutairi A, Stadnick E, Nair GM, Sadek MM, Birnie DH.

HeartRhythm Case Rep. 2016 Apr 21;2(4):324-327. doi: 10.1016/j.hrcr.2016.03.007. eCollection 2016 Jul. No abstract available.

46.

Adaptive CRT in patients with normal AV conduction and left bundle branch block: Does QRS duration matter?

Yamasaki H, Lustgarten D, Cerkvenik J, Birnie D, Gasparini M, Lee KL, Sekiguchi Y, Varma N, Lemke B, Starling RC, Aonuma K.

Int J Cardiol. 2017 Aug 1;240:297-301. doi: 10.1016/j.ijcard.2017.04.036. Epub 2017 Apr 12.

PMID:
28416247
47.

Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial.

Essebag V, Proietti R, Birnie DH, Wang J, Douketis J, Coutu B, Parkash R, Lip GYH, Hohnloser SH, Moriarty A, Oldgren J, Connolly SJ, Ezekowitz M, Healey JS.

Europace. 2017 Oct 1;19(10):1630-1636. doi: 10.1093/europace/euw409.

PMID:
28339794
48.

Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.

Sapp JL, Parkash R, Wells GA, Yetisir E, Gardner MJ, Healey JS, Thibault B, Sterns LD, Birnie D, Nery PB, Sivakumaran S, Essebag V, Dorian P, Tang AS.

Circ Arrhythm Electrophysiol. 2017 Mar;10(3). pii: e004875. doi: 10.1161/CIRCEP.116.004875.

PMID:
28292754
49.

Inter- and Intraobserver Agreement of 18F-FDG PET/CT Image Interpretation in Patients Referred for Assessment of Cardiac Sarcoidosis.

Ohira H, Ardle BM, deKemp RA, Nery P, Juneau D, Renaud JM, Klein R, Clarkin O, MacDonald K, Leung E, Nair G, Beanlands R, Birnie D.

J Nucl Med. 2017 Aug;58(8):1324-1329. doi: 10.2967/jnumed.116.187203. Epub 2017 Mar 2.

50.

Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]).

Parkash R, Wells GA, Sapp JL, Healey JS, Tardif JC, Greiss I, Rivard L, Roux JF, Gula L, Nault I, Novak P, Birnie D, Ha A, Wilton SB, Mangat I, Gray C, Gardner M, Tang ASL.

Circulation. 2017 May 9;135(19):1788-1798. doi: 10.1161/CIRCULATIONAHA.116.026230. Epub 2017 Feb 22.

PMID:
28228428

Supplemental Content

Loading ...
Support Center